<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-59579" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Convergence Insufficiency</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Goering</surname>
            <given-names>Michael</given-names>
          </name>
          <aff>Walter Reed National Military Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Drennan</surname>
            <given-names>Kirk B.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Moshirfar</surname>
            <given-names>Majid</given-names>
          </name>
          <aff>University of Utah/John Moran Eye Center; Hoopes Vision/HDR Research Center; Utah Lions Eye Bank</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michael Goering declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kirk Drennan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Majid Moshirfar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>18</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-59579.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Convergence insufficiency is a binocular vision disorder that results in symptoms such as eyestrain, headaches, and diplopia when looking at a near target. This activity will review the functional components underlying the condition, as well as the prevalence, definition, testing, diagnosis, proper treatment, and implications of the disorder. It will also include the role of the healthcare team in diagnosis and treatment.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the most common symptoms of convergence insufficiency.</p></list-item><list-item><p>Review the eye movements associated with convergence insufficiency.</p></list-item><list-item><p>Outline the diagnostic procedures for convergence insufficiency.</p></list-item><list-item><p>Explain the importance of interprofessional care coordination to enhance outcomes for patients with convergence insufficiency.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=59579&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=59579">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-59579.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Convergence insufficiency (CI) is a binocular vision disorder characterized by difficulty maintaining fusion while looking at a near target due to a tendency of the eyes to drift outwards. Commonly associated symptoms of CI include asthenopia (eye strain), diplopia, headaches, blurred vision, movement of print while reading, and difficulty with reading comprehension. Other notable symptoms exhibited after short periods of reading or prolonged near work include sleepiness and the inability to concentrate.<xref ref-type="bibr" rid="article-59579.r1">[1]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-59579.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Vergence eye movements (either convergence or divergence) are a summation of components in response to a stimulus. Vergence implies the movement of both eyes in conjunction with one another. In patients with convergence insufficiency, the etiology is presumed to be an innervational difference in these components that results in the limited capacity to converge with near demands. These components, often described as Maddox components of vergence, include tonic, proximal, fusional, and accommodative vergences.</p>
        <p>Tonic vergence describes the angle of vergence in the absence of a stimulus. The physiological position determined by tonic vergence often differs from the fusional vergence demand, and this difference is what constitutes an individual's phoria. A phoria manifests during a disruption of binocular vision, such as monocular viewing, and is an error of binocular alignment. Phorias are elicited in monocular viewing since, under binocular viewing, the other vergence components compensate for a difference in vergence demand.</p>
        <p>Another component is proximal vergence, which refers to vergence stimulated by a perceived distance or depth. Proximal vergence results in binocular fixation composed of large gaze shifts and comprises the majority of binocular shifts in fixation. Upon the completion of binocular shifts from proximal vergence, fusional vergence takes over to maintain vergence. Fusional, or disparity vergence, is the third component and utilizes feedback from retinal image disparity to maintain ocular alignment accurately through small eye movements. Accommodative convergence, the final component, describes the coupling relationship between stimulated convergence and the response to ensure clarity by the accommodative system.</p>
        <p>For CI, treatment options are tailored towards improving the tonic and proximal vergence components through procedural therapies, as they are adaptable with exercises. The contributions of fusional and accommodative vergences were found to be untrainable.<xref ref-type="bibr" rid="article-59579.r2">[2]</xref></p>
      </sec>
      <sec id="article-59579.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The prevalence of convergence insufficiency in school-age children documented in the literature ranges from 2% to 13%, with the most common figure cited in literature around 5%.<xref ref-type="bibr" rid="article-59579.r3">[3]</xref>&#x000a0;The prevalence of CI in older age groups, defined by those over the age of 19, was found to be approximately 1 in 6.<xref ref-type="bibr" rid="article-59579.r4">[4]</xref> Limited literature exists to compare these findings at this time. The lack of literature for CI in presbyopes is attributed to the effect presbyopia has on the accommodative convergence of the convergence system, as well as the natural tendency for individuals to become more exophoric with age.<xref ref-type="bibr" rid="article-59579.r5">[5]</xref>&#x000a0;There does not appear to be a correlation between gender and CI, although familial predisposition has yet to be examined.</p>
      </sec>
      <sec id="article-59579.s5" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>A definite diagnosis of CI requires specific physical evaluation criterion including:</p>
        <list list-type="bullet">
          <list-item>
            <p>Exophoria (XP) greater at near than far by at least 4 prism diopters</p>
          </list-item>
          <list-item>
            <p>Receded Near Point of Convergence (NPC) of 6 cm or more</p>
          </list-item>
          <list-item>
            <p>Insufficient Positive Fusional Vergence (PFV) to meet Sheard's Criterion</p>
          </list-item>
          <list-item>
            <p>Symptomatic according to the Convergence Insufficiency Symptom Survey (CISS)</p>
          </list-item>
        </list>
        <p>Phorias, the natural ocular alignment, are best measured by performing an alternating cover test and neutralizing eye movements to determine the magnitude. Exophoria describes temporally deviated ocular alignment, whereas esophoria describes nasally deviated alignment.&#x000a0;</p>
        <p>NPC measures the magnitude of convergence by following a target in towards the nose. The magnitude is measured when the patient subjectively reports diplopia or when the examiner objectively observes an eye drift outwards. This number is generally recorded in cm and is labeled as the "break" point. A normative value for this measurement is approximately 5 cm break from the nasal bridge. Three acceptable targets can be used to measure the breakpoint, including 1) an accommodative target, 2) a penlight, and 3) a penlight with red/green glasses.<xref ref-type="bibr" rid="article-59579.r6">[6]</xref></p>
        <p>PFV measures the magnitude of convergence by placing base out prism in front of the patient in increasing strengths until the patient reports blur then diplopia (or break). The strength of prism is then decreased until fusion (or recovery) is reported. It is recorded as Blur/Break/Recovery. PFV may be measured with either rotary prism in a phoropter or with a prism bar. Measurement repeatability between the two methods demonstrates the trend of higher breakpoints when measuring with a phoropter and higher recovery points when measuring with a prism bar; however, the two methods have been found to be repeatable within 6 prism diopters.<xref ref-type="bibr" rid="article-59579.r7">[7]</xref>&#x000a0;Sheard's criterion is a formula used to determine if a patient is likely to experience discomfort. It is calculated by measuring vergence ranges and states that the fusional reserve must be twice the phoric demand.<xref ref-type="bibr" rid="article-59579.r8">[8]</xref> For example, two patients are both 8 prism diopters exophoric (phoric demand=8). The first patient has PFV ranges of 14/20/16 (reserve=14) while the second has 18/24/20 (reserve=18). The first patient is more likely to be symptomatic than the second because the reserve for the first patient is less than 16 (2x8) while the reserve for the second patient is more than 16.</p>
        <p>The CISS is a survey designed to quantify a patient's severity of symptoms based on 15 questions associated with CI.<xref ref-type="bibr" rid="article-59579.r9">[9]</xref>&#x000a0;Questions are read aloud, and responses are selected from 5 possible answers, which are graded from 0 to 4 based on the frequency of symptoms (never, infrequent, sometimes, fairly often, or always) and are tallied for a total score. A&#x000a0;score of 16 or more is determined to be symptomatic and is specific for patients with CI.<xref ref-type="bibr" rid="article-59579.r10">[10]</xref><xref ref-type="bibr" rid="article-59579.r11">[11]</xref>&#x000a0;One factor in the administration of the CISS is to consider the near demand the patient regards for their symptoms, as emphasizing reading over other near related tasks has been suggested to overestimate near related symptoms.<xref ref-type="bibr" rid="article-59579.r12">[12]</xref></p>
      </sec>
      <sec id="article-59579.s6" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>A diagnosis of convergence insufficiency can be determined with a standard binocular vision examination. A definite diagnosis, as discussed previously, is determined with a cover test to determine one's phoria measurement, NPC, and PFV in either free space or behind a phoropter.</p>
      </sec>
      <sec id="article-59579.s7" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Office-based vergence therapy (OBVT) with home reinforcement is considered the first-line treatment option for symptomatic CI in children. OBVT has demonstrated to be significantly more effective in improving both symptoms and clinical signs than other accepted treatment options, including home-based pencil push-up therapy, home-based computer vergence therapy, base-in prism glasses, or surgery.<xref ref-type="bibr" rid="article-59579.r13">[13]</xref>&#x000a0;Clinical trials on the effectiveness of OBVT demonstrated success in approximately 75% of patients and were the only treatment option more effective than a placebo treatment.<xref ref-type="bibr" rid="article-59579.r14">[14]</xref></p>
        <p>OBVT, as documented in the literature, follows a weekly, hour-long office visit practicing 4 to 5 different procedures with a trained therapist. Procedures commonly&#x000a0;used in OBVT include Brock strings, barrel cards, vectograms, Life-Saver free-space fusion cards, and eccentric circles free-space fusion cards. After the visit, a handout is generally provided to the patient with instructions for home reinforcement procedures. Typical home reinforcement includes multiple procedures to be performed at home for 15 minutes per day, 5 times per week.<xref ref-type="bibr" rid="article-59579.r11">[11]</xref><xref ref-type="bibr" rid="article-59579.r15">[15]</xref>&#x000a0;OBVT has demonstrated significantly better (lower) mean scores on CISS, improved NPC, improved stereo acuity, and significantly improved PFV ranges compared to baseline measurements.<xref ref-type="bibr" rid="article-59579.r16">[16]</xref><xref ref-type="bibr" rid="article-59579.r17">[17]</xref><xref ref-type="bibr" rid="article-59579.r18">[18]</xref>&#x000a0;Although OBVT has not been shown to treat learning disabilities, it has been suggested that relieving clinical symptoms may help to reduce barriers to improved academic performance.<xref ref-type="bibr" rid="article-59579.r19">[19]</xref></p>
      </sec>
      <sec id="article-59579.s8" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnoses to consider include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Exotropia (XT): Exotropia is a form of strabismus in which either&#x000a0;eye misaligns outward.&#x000a0;Tropias, including XT, are clinically diagnosed by performing a unilateral cover (or cover-uncover) test,&#x000a0;whereas phorias&#x000a0;are determined using the alternating cover (or cross cover) test. During a unilateral cover test, the examiner covers one of the patient's eyes while observing the uncovered eye. A deviation of the uncovered eye indicates a tropia. The movement will be inward in the case of exotropia.&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Basic exophoria: When both distance and near are measured as exophoric, the diagnosis is basic exophoria. In the case of CI, the near phoria is greater than the distance.</p>
          </list-item>
          <list-item>
            <p>Acquired exotropia</p>
          </list-item>
          <list-item>
            <p>Diplopia</p>
          </list-item>
          <list-item>
            <p>&#x000a0;Dorsal midbrain syndrome</p>
          </list-item>
          <list-item>
            <p>Internuclear ophthalmoplegia</p>
          </list-item>
          <list-item>
            <p>Myasthenia gravis</p>
          </list-item>
          <list-item>
            <p>Oculomotor nerve palsy</p>
          </list-item>
          <list-item>
            <p>Thyroid eye disease</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-59579.s9" sec-type="Pertinent Studies and Ongoing Trials">
        <title>Pertinent Studies and Ongoing Trials</title>
        <p>The Convergence Insufficiency Treatment Trial (CITT) published two randomized clinical studies through a collaborative multicenter effort and was the first large-scale placebo-controlled, randomized clinical trial to study the various treatment options of&#x000a0;convergence insufficiency.&#x000a0;The first landmark study demonstrated that computer exercises, combined with OBVT, were more effective than pencil pushups or computer exercises alone for CI in children, ages 9 to 18 years old.<xref ref-type="bibr" rid="article-59579.r13">[13]</xref>&#x000a0;&#x000a0;</p>
        <p>The second CITT landmark study found comparable results for young adults, ages 19 to 30 years old. Vision&#x000a0;therapy/orthoptics&#x000a0;was compared head to head to pencil pushups and placebo and were the only&#x000a0;treatment&#x000a0;that produced clinically significant improvements in the NPC&#x000a0;and PFV.<xref ref-type="bibr" rid="article-59579.r20">[20]</xref>&#x000a0;A Cochrane Review suggested that OBVT was more effective than home-based vergence exercises or home-based computer vision therapy/orthoptics for children.<xref ref-type="bibr" rid="article-59579.r21">[21]</xref></p>
      </sec>
      <sec id="article-59579.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>There is a good prognosis for patients diagnosed with convergence insufficiency, with one study showing 73% improvement in CI symptoms and measured convergence following in-office and home-based therapy after 12 weeks.<xref ref-type="bibr" rid="article-59579.r13">[13]</xref>&#x000a0;Most patients remained symptom-free following one year after discontinuing treatment.<xref ref-type="bibr" rid="article-59579.r22">[22]</xref> Limitations for the prognosis are dependent on access to offices that can provide these therapy services and the cost of treatment. In patients with convergence insufficiency after concussion or trauma, there may be a prolonged recovery period.<xref ref-type="bibr" rid="article-59579.r23">[23]</xref></p>
      </sec>
      <sec id="article-59579.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Undiagnosed and, therefore, under-treatment of convergence insufficiency does not pose a significant health risk; however, symptoms characteristic of CI discussed previously will persist.</p>
      </sec>
      <sec id="article-59579.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should be educated regarding the effectiveness of vision therapy and the typical resolution. One deterrent to consider in discussing management strategies is the lack of coverage of OVT through most insurance companies, requiring patients to pay out of pocket for the costs.</p>
      </sec>
      <sec id="article-59579.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Vision is often only associated with visual acuity, particularly outside of eye care providers. This can complicate management and patient education for individuals with convergence insufficiency. The clinical presentation of convergence insufficiency patients, as discussed above, often includes a complaint of print moving on a page and difficulty with reading and other near-related tasks, and often results in reduced academic performance. That is why it is important for school nurses and teachers to consider possible binocular vision issues rather than solely attributing a lack of focus at school entirely to attention deficits, such as ADHD. Incidence reports linked a three-fold increase in the incidence of CI in patients diagnosed with attention deficit hyperactivity disorder (ADHD) compared to the population in general.<xref ref-type="bibr" rid="article-59579.r24">[24]</xref>&#x000a0;[Level 3] These findings are significant and present an opportunity for interprofessional referrals for patients diagnosed with ADHD, as treatment of CI, for those found to have it, will presumably enhance their outcomes. The relationship between ADHD and CI has been the subject of more recent studies, as it has been suggested that treating the symptoms of CI with OBVT has significantly improved academic performance by reducing adverse academic behaviors from baseline.<xref ref-type="bibr" rid="article-59579.r25">[25]</xref><xref ref-type="bibr" rid="article-59579.r26">[26]</xref>&#x000a0;[Level 1]</p>
        <p>Another consideration for optimally treating patients is the prescribed treatment. There appears to be a lack of consensus regarding prescribed treatment modalities, as they vary by profession. Although the first-line treatment for CI is OBVT with home reinforcement, the most commonly prescribed treatment by both optometrists and ophthalmologists is simple pencil push-ups for varying amounts of time, followed by home-based vergence therapy.<xref ref-type="bibr" rid="article-59579.r27">[27]</xref>&#x000a0;[Level 4] Providers should consider referring patients to a specialized therapist to complete OBVT to optimize patient outcomes.</p>
      </sec>
      <sec id="article-59579.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=59579&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=59579">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/convergence-insufficiency/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=59579">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/59579/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=59579">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-59579.s15">
        <title>References</title>
        <ref id="article-59579.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nunes</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Monteiro</surname>
                <given-names>PML</given-names>
              </name>
              <name>
                <surname>Ferreira</surname>
                <given-names>FBP</given-names>
              </name>
              <name>
                <surname>Nunes</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Convergence insufficiency and accommodative insufficiency in children.</article-title>
            <source>BMC Ophthalmol</source>
            <year>2019</year>
            <month>Feb</month>
            <day>21</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>58</fpage>
            <pub-id pub-id-type="pmid">30791877</pub-id>
          </element-citation>
        </ref>
        <ref id="article-59579.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arnoldi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Reynolds</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>A review of convergence insufficiency: what are we really accomplishing with exercises?</article-title>
            <source>Am Orthopt J</source>
            <year>2007</year>
            <volume>57</volume>
            <fpage>123</fpage>
            <page-range>123-30</page-range>
            <pub-id pub-id-type="pmid">21149167</pub-id>
          </element-citation>
        </ref>
        <ref id="article-59579.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rouse</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Borsting</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hyman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hussein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cotter</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Flynn</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Scheiman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gallaway</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>De Land</surname>
                <given-names>PN</given-names>
              </name>
            </person-group>
            <article-title>Frequency of convergence insufficiency among fifth and sixth graders. The Convergence Insufficiency and Reading Study (CIRS) group.</article-title>
            <source>Optom Vis Sci</source>
            <year>1999</year>
            <month>Sep</month>
            <volume>76</volume>
            <issue>9</issue>
            <fpage>643</fpage>
            <page-range>643-9</page-range>
            <pub-id pub-id-type="pmid">10498006</pub-id>
          </element-citation>
        </ref>
        <ref id="article-59579.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghadban</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Martinez</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Diehl</surname>
                <given-names>NN</given-names>
              </name>
              <name>
                <surname>Mohney</surname>
                <given-names>BG</given-names>
              </name>
            </person-group>
            <article-title>The incidence and clinical characteristics of adult-onset convergence insufficiency.</article-title>
            <source>Ophthalmology</source>
            <year>2015</year>
            <month>May</month>
            <volume>122</volume>
            <issue>5</issue>
            <fpage>1056</fpage>
            <page-range>1056-9</page-range>
            <pub-id pub-id-type="pmid">25626756</pub-id>
          </element-citation>
        </ref>
        <ref id="article-59579.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bruce</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Atchison</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Bhoola</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Accommodation-convergence relationships and age.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>1995</year>
            <month>Feb</month>
            <volume>36</volume>
            <issue>2</issue>
            <fpage>406</fpage>
            <page-range>406-13</page-range>
            <pub-id pub-id-type="pmid">7843910</pub-id>
          </element-citation>
        </ref>
        <ref id="article-59579.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scheiman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gallaway</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Frantz</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Peters</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Hatch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cuff</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>GL</given-names>
              </name>
            </person-group>
            <article-title>Nearpoint of convergence: test procedure, target selection, and normative data.</article-title>
            <source>Optom Vis Sci</source>
            <year>2003</year>
            <month>Mar</month>
            <volume>80</volume>
            <issue>3</issue>
            <fpage>214</fpage>
            <page-range>214-25</page-range>
            <pub-id pub-id-type="pmid">12637833</pub-id>
          </element-citation>
        </ref>
        <ref id="article-59579.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Antona</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Barrio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Barra</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gonzalez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sanchez</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Repeatability and agreement in the measurement of horizontal fusional vergences.</article-title>
            <source>Ophthalmic Physiol Opt</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>28</volume>
            <issue>5</issue>
            <fpage>475</fpage>
            <page-range>475-91</page-range>
            <pub-id pub-id-type="pmid">18761485</pub-id>
          </element-citation>
        </ref>
        <ref id="article-59579.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dalziel</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Effect of vision training on patients who fail Sheard's criterion.</article-title>
            <source>Am J Optom Physiol Opt</source>
            <year>1981</year>
            <month>Jan</month>
            <volume>58</volume>
            <issue>1</issue>
            <fpage>21</fpage>
            <page-range>21-3</page-range>
            <pub-id pub-id-type="pmid">7212013</pub-id>
          </element-citation>
        </ref>
        <ref id="article-59579.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Borsting</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Rouse</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Scheiman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cotter</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kulp</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>London</surname>
                <given-names>R</given-names>
              </name>
              <collab>Convergence Insufficiency Treatment Trial Group</collab>
            </person-group>
            <article-title>Validity and reliability of the revised convergence insufficiency symptom survey in children aged 9 to 18 years.</article-title>
            <source>Optom Vis Sci</source>
            <year>2003</year>
            <month>Dec</month>
            <volume>80</volume>
            <issue>12</issue>
            <fpage>832</fpage>
            <page-range>832-8</page-range>
            <pub-id pub-id-type="pmid">14688547</pub-id>
          </element-citation>
        </ref>
        <ref id="article-59579.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rouse</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Borsting</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Cotter</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Kulp</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Scheiman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Barnhardt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bade</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yamada</surname>
                <given-names>T</given-names>
              </name>
              <collab>Convergence Insufficiency Treatment Trial (CITT) Investigator Group</collab>
            </person-group>
            <article-title>Validity of the convergence insufficiency symptom survey: a confirmatory study.</article-title>
            <source>Optom Vis Sci</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>86</volume>
            <issue>4</issue>
            <fpage>357</fpage>
            <page-range>357-63</page-range>
            <pub-id pub-id-type="pmid">19289977</pub-id>
          </element-citation>
        </ref>
        <ref id="article-59579.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scheiman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Cotter</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kulp</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rouse</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Borsting</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>London</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wensveen</surname>
                <given-names>J</given-names>
              </name>
              <collab>Convergence Insufficiency Treatment Trial Study Group</collab>
            </person-group>
            <article-title>A randomized clinical trial of treatments for convergence insufficiency in children.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2005</year>
            <month>Jan</month>
            <volume>123</volume>
            <issue>1</issue>
            <fpage>14</fpage>
            <page-range>14-24</page-range>
            <pub-id pub-id-type="pmid">15642806</pub-id>
          </element-citation>
        </ref>
        <ref id="article-59579.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clark</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Convergence Insufficiency Symptom Survey Scores for Reading Versus Other Near Visual Activities in School-Age Children.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>160</volume>
            <issue>5</issue>
            <fpage>905</fpage>
            <page-range>905-912.e2</page-range>
            <pub-id pub-id-type="pmid">26275474</pub-id>
          </element-citation>
        </ref>
        <ref id="article-59579.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <collab>Convergence Insufficiency Treatment Trial Study Group</collab>
            <article-title>Randomized clinical trial of treatments for symptomatic convergence insufficiency in children.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>126</volume>
            <issue>10</issue>
            <fpage>1336</fpage>
            <page-range>1336-49</page-range>
            <pub-id pub-id-type="pmid">18852411</pub-id>
          </element-citation>
        </ref>
        <ref id="article-59579.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scheiman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rouse</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kulp</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Cotter</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hertle</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>GL</given-names>
              </name>
            </person-group>
            <article-title>Treatment of convergence insufficiency in childhood: a current perspective.</article-title>
            <source>Optom Vis Sci</source>
            <year>2009</year>
            <month>May</month>
            <volume>86</volume>
            <issue>5</issue>
            <fpage>420</fpage>
            <page-range>420-8</page-range>
            <pub-id pub-id-type="pmid">19319008</pub-id>
          </element-citation>
        </ref>
        <ref id="article-59579.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scheiman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kulp</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Cotter</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Gallaway</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Boas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Coulter</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hopkins</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tamkins</surname>
                <given-names>S</given-names>
              </name>
              <collab>Convergence Insufficiency Treatment Trial Study Group</collab>
            </person-group>
            <article-title>Vision therapy/orthoptics for symptomatic convergence insufficiency in children: treatment kinetics.</article-title>
            <source>Optom Vis Sci</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>87</volume>
            <issue>8</issue>
            <fpage>593</fpage>
            <page-range>593-603</page-range>
            <pub-id pub-id-type="pmid">20543758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-59579.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scheiman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Talasan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Alvarez</surname>
                <given-names>TL</given-names>
              </name>
            </person-group>
            <article-title>Objective Assessment of Disparity Vergence after Treatment of Symptomatic Convergence Insufficiency in Children.</article-title>
            <source>Optom Vis Sci</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>96</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-16</page-range>
            <pub-id pub-id-type="pmid">30570596</pub-id>
          </element-citation>
        </ref>
        <ref id="article-59579.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <collab>Convergence Insufficiency Treatment Trial (CITT) Study Group</collab>
            <article-title>The convergence insufficiency treatment trial: design, methods, and baseline data.</article-title>
            <source>Ophthalmic Epidemiol</source>
            <year>2008</year>
            <season>Jan-Feb</season>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>24</fpage>
            <page-range>24-36</page-range>
            <pub-id pub-id-type="pmid">18300086</pub-id>
          </element-citation>
        </ref>
        <ref id="article-59579.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aletaha</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Daneshvar</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mosallaei</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bagheri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Khalili</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Comparison of Three Vision Therapy Approaches for Convergence Insufficiency.</article-title>
            <source>J Ophthalmic Vis Res</source>
            <year>2018</year>
            <season>Jul-Sep</season>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>307</fpage>
            <page-range>307-314</page-range>
            <pub-id pub-id-type="pmid">30090188</pub-id>
          </element-citation>
        </ref>
        <ref id="article-59579.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McGregor</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Convergence insufficiency and vision therapy.</article-title>
            <source>Pediatr Clin North Am</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>61</volume>
            <issue>3</issue>
            <fpage>621</fpage>
            <page-range>621-30</page-range>
            <pub-id pub-id-type="pmid">24852157</pub-id>
          </element-citation>
        </ref>
        <ref id="article-59579.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scheiman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Cotter</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kulp</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rouse</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Borsting</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>London</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wensveen</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>A randomized clinical trial of vision therapy/orthoptics versus pencil pushups for the treatment of convergence insufficiency in young adults.</article-title>
            <source>Optom Vis Sci</source>
            <year>2005</year>
            <month>Jul</month>
            <volume>82</volume>
            <issue>7</issue>
            <fpage>583</fpage>
            <page-range>583-95</page-range>
            <pub-id pub-id-type="pmid">16044063</pub-id>
          </element-citation>
        </ref>
        <ref id="article-59579.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scheiman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gwiazda</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Non-surgical interventions for convergence insufficiency.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2011</year>
            <month>Mar</month>
            <day>16</day>
            <issue>3</issue>
            <fpage>CD006768</fpage>
            <pub-id pub-id-type="pmid">21412896</pub-id>
          </element-citation>
        </ref>
        <ref id="article-59579.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <collab>Convergence Insufficiency Treatment Trial Study Group</collab>
            <article-title>Long-term effectiveness of treatments for symptomatic convergence insufficiency in children.</article-title>
            <source>Optom Vis Sci</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>86</volume>
            <issue>9</issue>
            <fpage>1096</fpage>
            <page-range>1096-103</page-range>
            <pub-id pub-id-type="pmid">19668097</pub-id>
          </element-citation>
        </ref>
        <ref id="article-59579.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DuPrey</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Webner</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lyons</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kucuk</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Ellis</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Cronholm</surname>
                <given-names>PF</given-names>
              </name>
            </person-group>
            <article-title>Convergence Insufficiency Identifies Athletes at Risk of Prolonged Recovery From Sport-Related Concussion.</article-title>
            <source>Am J Sports Med</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>45</volume>
            <issue>10</issue>
            <fpage>2388</fpage>
            <page-range>2388-2393</page-range>
            <pub-id pub-id-type="pmid">28511593</pub-id>
          </element-citation>
        </ref>
        <ref id="article-59579.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Granet</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Gomi</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Ventura</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Miller-Scholte</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The relationship between convergence insufficiency and ADHD.</article-title>
            <source>Strabismus</source>
            <year>2005</year>
            <month>Dec</month>
            <volume>13</volume>
            <issue>4</issue>
            <fpage>163</fpage>
            <page-range>163-8</page-range>
            <pub-id pub-id-type="pmid">16361187</pub-id>
          </element-citation>
        </ref>
        <ref id="article-59579.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Borsting</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Kulp</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Scheiman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Amster</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Cotter</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Coulter</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Fecho</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gallaway</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Granet</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hertle</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rodena</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yamada</surname>
                <given-names>T</given-names>
              </name>
              <collab>CITT Study Group</collab>
            </person-group>
            <article-title>Improvement in academic behaviors after successful treatment of convergence insufficiency.</article-title>
            <source>Optom Vis Sci</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>89</volume>
            <issue>1</issue>
            <fpage>12</fpage>
            <page-range>12-8</page-range>
            <pub-id pub-id-type="pmid">22080400</pub-id>
          </element-citation>
        </ref>
        <ref id="article-59579.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barnhardt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cotter</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Scheiman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kulp</surname>
                <given-names>MT</given-names>
              </name>
              <collab>CITT Study Group</collab>
            </person-group>
            <article-title>Symptoms in children with convergence insufficiency: before and after treatment.</article-title>
            <source>Optom Vis Sci</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>89</volume>
            <issue>10</issue>
            <fpage>1512</fpage>
            <page-range>1512-20</page-range>
            <pub-id pub-id-type="pmid">22922781</pub-id>
          </element-citation>
        </ref>
        <ref id="article-59579.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scheiman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>de</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Cotter</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Borsting</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>London</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rouse</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>A survey of treatment modalities for convergence insufficiency.</article-title>
            <source>Optom Vis Sci</source>
            <year>2002</year>
            <month>Mar</month>
            <volume>79</volume>
            <issue>3</issue>
            <fpage>151</fpage>
            <page-range>151-7</page-range>
            <pub-id pub-id-type="pmid">11913841</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
